What's new in point-of-care testing in 2005?

Point of Care

Volumn 5, Issue 2, 2006, Pages 74-76

  Melanson, Stacy E F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Advances; Cardiac; Coagulation; Diabetes; Infectious disease; Point of care; Technology; Toxicology; Utilization

Indexed keywords

EID: 33746641777     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/00134384-200606000-00007     Document Type: Review

References (40)

1. von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin Biochem. 2005;38:591-606.
2. Cho JH, Pack EH, Cho IH, et al. An enzyme immunoanalytical system based on sequential cross-flow chromatography. Anal Chem. 2005;77:4091-4097.
3. Patel HD, Livsey SA, Swann RA, et al. Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload? J Clin Pathol. 2005;58:951-954.
4. Meier FA, Jones BA. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med. 2005;129:1262-1267.
5. Mshelia DS, Buba AA. Point of care testing: a delight or a dilemma in the developing world? An overview. Niger Postgrad Med J. 2005;12:136-139.
6. Shephard MD, Mazzachi BC, Shephard AK, et al. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health. 2005;5:371.
7. Shephard MD, Gill JP. An innovative Australian point-of-care model for urine albumin:creatinine ratio testing that supports diabetes management in indigenous medical services and has international application. Ann Clin Biochem. 2005;42:208-215.
8. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. Approved IFCC recommendations on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51:1573-1576.
9. Boyd R, Leigh B, Stuart P. Capillary versus venous bedside blood glucose estimations. Emerg Med J. 2005;22:177-179.
10. Rao LV, Jakubiak F, Sidwell JS, et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356:178-183.
11. 1C and blood glucose in a remote aboriginal Australian community. Med J Aust. 2005;16:524-527.
12. Greaves RF, Northfield JA, Cameron FJ. Haemoglobin A1c: evaluation of three point of care analysers for use in a pediatric diabetes clinic. Ann Clin Biochem. 2005;42:124-129.
13. Harris S, Ng R, Syed H, et al. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis. Diabet Med. 2005;22:221-224.
14. Yamaguchi M, Kambe S, Eto T, et al. Point of care testing system via enzymatic method for the rapid, efficient assay of glycated albumin. Biosens Bioelectron. 2005;21:426-432.
15. van den Besselaar AM, Hockstra MM. Long-term stability and reproducibility of CoaguChek test strips. Thromb Haemost. 2005;93:1189-1192.
16. Kitchen DP, Kitchen S, Jennings I, et al. Point of care testing by health care professionals: current practice amongst the UK National External Quality Assessment Scheme Participants. Br J Haematol. 2005;130:320-321.
17. Dorfman DM, Goonan EM, Boutilier MK, et al. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med. 2005;10:23-27.
18. McBane RD, Felty CL, Hartgers ML, et al. Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing for programs. Mayo Clin Proc. 2005;80:181-186.
19. Phillips EM, Buchan DA, Newman N, et al. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio. Pharmacotherapy. 2005;25:1341-1347.
20. Gardiner C, Williams K, Mackie IJ, et al. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol. 2005;128:242-247.
21. Sunderji R, Gin K, Shalansky K, et al. Clinical impact of point-of-care laboratory measurement of anticoagulation. Am J Clin Pathol. 2005;123:184-188.
22. Wittkowsky AK, Sekreta CM, Nutescu EA, et al. Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners. Pharmacotherapy. 2005;25:265-269.
23. Freyburger G, Reboul MP, Labrouche S, et al. Diagnosis accuracy of a new challenger for thrombosis exclusion, the Stratus CS DDMR. Clin Chim Acta. 2005;354:181-189.
24. Akutsu K, Sato N, Yamamoto T, et al. A rapid beside D-dimer assay (cardiac D-dimer) for screening of clinically suspected acute aortic dissection. Circ J. 2005;69:397-403.
25. Singer AJ, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency chest pain patients. Ann Emerg Med. 2005;45:587-591.
26. Hallani H, Leung DY, Newland E, et al. Use of a quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes. Intern Med J. 2005;35:560-562.
27. DiSerio F, Amodio G, Varraso L, et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Clin Chem Lab Med. 2005;43:202-209.
28. Prontera C, Storti S, Emdin M, et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin Chem. 2005;51:1274-1276.
29. Flynn PA, da Graca RL, Auld PA, et al. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr. 2005;147:38-42.
30. Oh SW, Moon JD, Park SY, et al. Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing. Clin Chim Acta. 2005;356:172-177.
31. Doyle NM, Levison JE, Gardner MO. Rapid HIV versus enzyme-lined immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis. Am J Obstet Gynecol. 2005;193:1280-1285.
32. Kendrick SR, Kroc KA, Withum D, et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr. 2005;38:142-146.
33. Tomaszewski C, Runge J, Gibbs M, et al. Evaluation of a rapid bedside toxicology screen in patients with suspected drug toxicity. J Emerg Med. 2005;28:389-394.
34. Dale C, Aulaqi AA, Baker J, et al. Assessment of a point-of-care test for paracetamol and salicylate in blood. QJM. 2005;98:113-118.
35. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol. 2005;43:684-687.
36. Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293:810-816.
37. Burne P, Mitchell S, Rees Smith B. Point-of-care assays for autoantibodies to thyroid peroxidase and to thyroglobulin. Thyroid. 2005;15:1005-1010.
38. Herold TJ, Whittaker DS, Glynn T. Determining the accuracy of a rapid point-of-care test for determining Rh(D) phenotype. Acad Emerg Med. 2005;12:474-476.
39. Panz VR, Raal FJ, Paiker J, et al. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J S Afr. 2005;16:112-117.
40. Rossi AF, Khan DM, Hannan R, et al. Goal-directed medical therapy and point-of-care testing improve outcomes after congenital heart surgery. Intensive Care Med. 2005;31:98-104.